Punjab CM Bhagwant Mann Seeks Korean Investment
Punjab Chief Minister Bhagwant Mann meets Indian Ambassador in Seoul, outlines vision for collaboration in agri-tech, defence & infra. Delegation to engage with major Korean firms.
Category : Search result: pharmaceutical industry Punjab
Punjab CM Bhagwant Mann's Investment Pitch in Osaka
Punjab Chief Minister Bhagwant Mann held a business roadshow in Osaka, Japan, inviting investment in key sectors like agriculture, IT, and manufacturing. Discover his vision for transforming Punjab into an industrial hub.
Himachal Pharma Sector Faces Major Trust Crisis
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
Nivin Pauly's 'Pharma' Trailer Targets Unethical Drug Practices
Nivin Pauly's OTT debut 'Pharma' trailer reveals a medical rep exposing dangerous drugs. The series premieres on JioCinema December 19 in 7 languages. Read more.
Japanese firm Toppan invests Rs 400 crore in Punjab
Japanese firm Toppan Speciality Films signs Rs 400 crore investment pact with Punjab, plans a skilling centre. CM Bhagwant Mann announces deal during Japan visit ahead of 2026 Investors' Summit.
Punjab CM woos Japanese investors in Tokyo for key sectors
Punjab CM Bhagwant Mann invites Japanese firms to invest in advanced manufacturing, mobility & renewable energy. He highlights the upcoming Progressive Punjab Investors' Summit for collaboration.
Punjab brick kilns face extinction amid rising taxes
Punjab's brick kiln industry shrinks from 2,700 to 1,500 units in 3 years. A triple burden of 18% GST on coal, soaring mining royalty & tech upgrades threatens rural jobs & hikes brick prices. Read more.
Punjab CM Mann leads delegation to Japan, South Korea for investment
Punjab CM Bhagwant Mann leads a high-level delegation to Japan and South Korea for investor outreach ahead of the Progressive Punjab Summit. The mission aims to boost economic ties and engage with the diaspora.
Wockhardt's Zaynich NDA Accepted by USFDA, Shares Soar 19%
Mumbai's Wockhardt creates history as USFDA accepts its New Drug Application for antibiotic Zaynich, a first for an Indian firm. Shares surge 19%. Read more.
Wockhardt Stock Jumps on US FDA Nod for Novel Antibiotic
Wockhardt shares surged 19.3% after US FDA accepted its New Drug Application for Zaynich, a first-in-class antibiotic. This marks a historic first for an Indian pharma company's New Chemical Entity.
Punjab Cabinet Nods 300 Specialist Doctors
Punjab cabinet approves empanelment of 300 specialist doctors, new border area incentives, GPS mining vehicle tracking & revised tender limits to boost public services.
Indian Pharma Pivots to Innovative Products: PHARMEXCIL
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma IPO Subscribed 94 Times
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Congress Losing Ground to AAP in Punjab
Congress faces mounting challenges in Punjab as AAP gains momentum. Key leaders defect, organizational structure weakens. Can Congress recover before elections?
Global Tenders for 65+ Patented Drugs in India
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Ramaswamy's net worth jumps 80% to $1.8 billion
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Punjab's Justice Plea: Land of Five Rivers Seeks Capital
Punjab's emotional appeal for justice: From Partition trauma to Green Revolution contributions, the state demands its rightful capital Chandigarh. Read the compelling narrative of sacrifice and resilience.
Aurobindo Pharma China Facility Targets Break-Even by FY26
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister's Directive to Pharma Industry
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US Trade Deal: $500B Target & Stock Gains
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharma Soars 10% Despite 47% Yearly Loss
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Pakistan Factory Boiler Blast Kills 15 in Punjab
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Summit 2025: Pharma Partnerships for India's Growth
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India Sends 3.5 Tonnes Medical Aid to Seychelles
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Page 1 of 4